Safety and Tolerability of GX-I7 in HPV-infected Female Volunteers

NCT03144934 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Human Papillomavirus

Interventions

DRUG: GX-I7
DRUG: Placebo

Sponsor

Genexine, Inc.